| European Case Law Identifier: | ECLI:EP:BA:2015:T004512.20151109 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 09 November 2015 | ||||||||
| Case number: | T 0045/12 | ||||||||
| Application number: | 01203170.4 | ||||||||
| IPC class: | A61K 31/4439 A61K 31/64 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Pharmaceutical composition comprising pioglitazone and glimepiride for use in treatment of diabetes | ||||||||
| Applicant name: | Takeda Pharmaceutical Company Limited | ||||||||
| Opponent name: | Laboratorios CINFA, S.A. Teva Pharmaceutical Industries Ltd. |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request - allowable (yes) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t120045eu1.html
Date retrieved: 17 May 2021